ETF Managers Group’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$698K Sell
18,630
-1,061
-5% -$45K 0.02% 334
2022
Q4
$944K Buy
19,691
+2,187
+12% +$85.8K 0.04% 164
2022
Q3
$420K Sell
17,504
-919
-5% -$23.3K 0.01% 494
2022
Q2
$381K Buy
18,423
+1,342
+8% +$31.1K 0.01% 560
2022
Q1
$411K Buy
17,081
+1,127
+7% +$24.6K 0.01% 502
2021
Q4
$406K Sell
15,954
-3,102
-16% -$72.1K 0.01% 548
2021
Q3
$491K Buy
19,056
+3,901
+26% +$94.6K 0.01% 538
2021
Q2
$342K Sell
15,155
-451
-3% -$9.23K 0.01% 580
2021
Q1
$291K Sell
15,606
-9,176
-37% -$231K 0.01% 592
2020
Q4
$718K Sell
24,782
-3,996
-14% -$149K 0.02% 277
2020
Q3
$1.48M Buy
+28,778
New +$1.15M 0.05% 174

Other funds holding PCVX